Results for tag: "Peptide Cancer Vaccine"

The Peptide Cancer Vaccine market is a subset of the larger Cancer Vaccine market. Peptide Cancer Vaccines are a type of therapeutic vaccine that use peptides, or small pieces of proteins, to stimulate the body’s immune system to recognize and attack cancer cells. These vaccines are designed to target specific cancer cells, and are used to treat a variety of cancers, including melanoma, prostate cancer, and breast cancer. Peptide Cancer Vaccines are typically administered in combination with other treatments, such as chemotherapy or radiation therapy. They are also used in combination with other immunotherapies, such as monoclonal antibodies, to enhance the body’s immune response to cancer cells. The Peptide Cancer Vaccine market is growing rapidly, as more research is conducted into the efficacy of these vaccines. Companies in the market include Merck, GlaxoSmithKline, Pfizer, Bristol-Myers Squibb, and Sanofi. Show Less Read more